{"title":"Developing A Novel Coumarone-Phenyl Amide Functionalized [Gd(III)-Pt(IV)] Complex as High T1, T2 Relaxive M-MRI Contrast Agent for Cancer Diagnosis","authors":"Lurthu Pushparaj, U. Devi","doi":"10.2139/ssrn.3814333","DOIUrl":"https://doi.org/10.2139/ssrn.3814333","url":null,"abstract":"Pt(IV) cored Gd(III) metal complex as a multimodal MRI contrast agent for cancer diagnosis is reported. The hetero nuclear complex [Pr-(DO3-Ch-Ph-Am-Gd(III))2Pt(II)] is highly soluble in water and stable at room temperature. The complex shows high longitudinal (r1p = 24.43 mM-1 s-1) and transversal (r2p = 38.61 mM-1 s-1) relaxivity values in neat aqueous solution at pH =7 and at 27 oC. The relaxivity value of the complex is greater than the low molecular weight, FDA approved MRI contrast agents. The presence of two water molecules in the first coordination sphere and a replaceable hydrogen atom in the linker enhances the proton relaxation rate and gives a huge relaxivity value. The r2p/r1P ratio of 1.58 confirms that the complex is a T1-weighted contrast agent. The presence of high polar coumarone pendant arm and high rigid acridone moieties in the complex make the complex as better anticancer agent for ovarian cancer. The high polar nature of the coumarone, phenyl amide, acridone moiety will show better binding efficiency with ovarian cancer creating CA125 glycoprotein.","PeriodicalId":368671,"journal":{"name":"BiochemRN: Medical Biology (Topic)","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114530691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}